Jul 10, 2021 by Jason HawthorneHere's the Next Stock I'm Going to BuyA temporary slowdown is giving investors a rare opportunity to buy shares at a reasonable valuation.
Jul 9, 2021 by Jason HawthorneWhy Lucira Health Is Rocketing Higher TodayThe company may be the beneficiary of another social media-inspired buying frenzy.
Jul 9, 2021 by Jason HawthorneWhy Shares of Pfizer Are Rising TodayThe company is laying out a timeline for vaccine boosters as the Delta variant takes over.
Jul 8, 2021 by Jason HawthorneWhy Illumina Was Up 17% in JuneThe company's liquid-biopsy spinoff can reportedly detect early-stage cancer in blood samples.
Jul 8, 2021 by Jason HawthorneWhy Beam Therapeutics Climbed 64.5% in JuneA gene editing milestone sent the entire sector higher last month.
Jul 7, 2021 by Jason HawthorneWhy Novavax Was Up 44% in JuneThe company finally got some good news about its vaccine production schedule.
Jul 7, 2021 by Jason HawthorneWhy Teladoc Stock Is Falling TodayInvestors may be reading too much into declining COVID numbers in the U.S.
Jul 1, 2021 by Jason HawthorneWhy Sorrento Therapeutics Is Climbing TodayRising numbers of new COVID-19 cases might have investors anticipating strong demand for the company's 15-minute test.
Jun 30, 2021 by Jason HawthorneWill Johnson & Johnson Be a Trillion-Dollar Stock by 2030?To clear the hurdle, the healthcare giant will need to stay richly valued.
Jun 30, 2021 by Jason Hawthorne3 Reasons Shareholders of Moderna and BioNTech May Be In for a ShockA recent study undermines one key assumption underpinning the stocks' recent gains.
Jun 29, 2021 by Jason Hawthorne3 Reasons to Buy BioNTech, And 1 Reason To SellDespite the vaccine windfall and an impressive pipeline, shareholders might need the company's encore sooner than expected.
Jun 29, 2021 by Jason Hawthorne3 Reasons to Buy Johnson & Johnson, and 1 Reason to SellThe company has a steady business but a big liability hanging over its head.
Jun 28, 2021 by Jason HawthorneWhy Beam Therapeutics Jumped TodayA first for CRISPR-Cas9 might signal a new phase in the gene-editing revolution.
Jun 28, 2021 by Jason HawthorneForget Meme Stocks and Cryptocurrency: This Healthcare IPO Could Make You RicherIts fast-growing platform is entrenched in physicians' workflows, and it's already turning a profit.
Jun 26, 2021 by Jason HawthorneIs It Too Late to Buy Cassava Sciences Stock?Just because the stock has had a massive run doesn't mean its biggest gains are behind it.
Jun 25, 2021 by Jason HawthorneForget Dogecoin: These Dogs of the Dow Are More Likely to Make You RichIf you've been bitten by the shiba inu, try investing in the type of dog that pays.
Jun 25, 2021 by Jason HawthorneWhy Aflac Might Be the Best Long-Term Dividend StockThis insurer has the look of a high-yielder with staying power.
Jun 24, 2021 by Jason Hawthorne3 Reasons I Just Bought Fulgent Genetics StockOngoing COVID-19 testing and deals in the core business could keep growth high for longer than many think.
Jun 24, 2021 by Jason Hawthorne3 Revolutionary Stocks That Can Make You RichArtificial intelligence and machine learning are competitive advantages they've had from the start.
Jun 24, 2021 by Jason HawthorneHere's How to Find the Best Dividend StocksGetting juicy payouts that last requires balancing views of the company's past, present, and future.
